Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Acepodia's Approach To ACC & CAR Manufacturing Scalability

    Acepodia's Approach To ACC & CAR Manufacturing Scalability

    FromBusiness Of Biotech

    Start listeningView podcast show

    Acepodia's Approach To ACC & CAR Manufacturing Scalability

    FromBusiness Of Biotech

    ratings:
    Length:
    43 minutes
    Released:
    Jan 18, 2021
    Format:
    Podcast episode

    Description

    Acepodia CEO, President, & Co-founder Dr. Sonny Hsiao and Dr. Mark Gilbert, VP of R&D, join Erin Harris and Matt Pillar for a discussion on the company's approach to dramatically reducing the cost of cell therapy development, manufacturing, and administration via its oNK, CAR, and ACC candidates.
    Released:
    Jan 18, 2021
    Format:
    Podcast episode

    Titles in the series (100)

    The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, formerly GE Healthcare Life Sciences.